Exhibit 107
Form S-8
(Form Type)
Catalyst Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered (1) | Proposed Price Per Unit (2) | Maximum Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||
| Primary Offering of Securities: | ||||||||||||||||||||||||
Fees to be Paid | Equity | Common Stock, par value $0.001 per share (1) | 457(h) | 3,000,000 | $16.07 (2) | $48,210,000 | — | $— | — | — | — | — | ||||||||||||
Fees to be Paid | Total Registration Fee | — | — | 3,000,000 | $16.07 (2) | $48,210,000 | 0.00014760 | $7,116 | — | — | — | — | ||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||
| Total Offering Amounts | $48,210,000 | $7,116 | ||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $7,116 | |||||||||||||||||||||||
| (1) | Including such indeterminate amount of common stock as may be issued from time to time at indeterminate prices or upon conversion of common stock purchase options and restricted stock units, as the case may be. |
| (2) | Estimated solely for the purpose of calculating the registration fee which was computed in accordance with Rule 457(c) under the Securities Act of 1933, as amended, on the basis of the average of the high and low sales prices per share of the common stock as reported on the Nasdaq Capital Market on May 29, 2024. |
Table 2: Fee Offset Claims and Sources
Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset | Security Type Associated with Fee Offset Claimed | Security Title Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source | ||||||||||||
| Rule 457(p) | ||||||||||||||||||||||
Fee Offset Claims | Catalyst Pharmaceuticals, Inc. | S-8 | — | — | — | — | — | — | — | — | — | |||||||||||
Fee Offset Sources | Catalyst Pharmaceuticals, Inc. | S-8 | — | — | \ — | — | — | — | — | — | — | |||||||||||
